Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Leerink Partners Maintains Outperform on Zai Lab, Raises Price Target to $75

Author: Benzinga Newsdesk | June 30, 2025 02:43pm
Leerink Partners analyst Jonathan Chang maintains Zai Lab (NASDAQ:ZLAB) with a Outperform and raises the price target from $73 to $75.

Posted In: ZLAB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist